In our current study, we thus prioritized HSP90AB1 inhibition, which had been shown to improve skeletal muscle mitochondrial metabolism in a diabetes mouse model (Jing et al., 2018). This evidence concerns the gene HSP90AB1 and diabetes mellitus.